ʻO Dalfampridine

Anter

• Ma mua o ka lawe ʻana i ka dalfampridine,
• Hoʻokumu paha ʻo Dalfampridine i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:
• Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli, e kāhea i kāu kauka a i ʻole e kiʻi koke i ka lāʻau olakino olakino
• Hiki i nā ʻōuli o ka overdose ke hoʻopili i kēia mau mea:

Hoʻohana ʻia ʻo Dalfampridine e hoʻomaikaʻi i ka hele wāwae i ka poʻe i loaʻa ka sclerosis nunui (MS; kahi maʻi kahi e holo pono ʻole ai nā ʻalalā a hiki ke kumu i ka nāwaliwali, numbness, nalo ʻana o ka hoʻohui ʻana o nā mākala, a me nā pilikia me ka ʻike, ka ʻōlelo, a me ka kaohi o ka maʻi ʻaʻa). Hiki ke hoʻohana wale ʻia ʻo Dalfampridine a i ʻole me nā lāʻau ʻē aʻe e kaohi i nā ʻōuli o MS. Aia ʻo Dalfampridine i ka papa o nā lāʻau i kapa ʻia he blockers o ka potassium channel. Hana ia me ka hoʻoikaika ʻana i nā hōʻailona i hoʻouna ʻia e ka lolo ma o nā ʻalolo i hōʻino ʻia e MS.

Hele mai ʻo Dalfampridine ma ke ʻano he papa hoʻolōʻihi hoʻolōʻihi ʻia e lawe ma ka waha. Lawe mau ʻia me ka ʻai ʻole a i ʻole ʻelua mau manawa i ka lā. E hakahaka i kāu mau kaha i lawe ʻoe i hoʻokahi mahele ma kahi o kēlā me kēia 12 hola, a lawe i ka dalfampridine ma nā manawa like i kēlā me kēia lā. E hāhai pono i nā ʻōkuhi i kāu lepili kuhikuhi, a nīnau i kāu kauka a kauka paha e wehewehe i kahi ʻāpana āu i maopopo ʻole ai. Lawe pono i ka dalfampridine e like me ke kuhikuhi. Mai lawe i ka mea ʻoi aku a liʻiliʻi paha o ia mea a lawe pinepine iā ia ma mua o ka mea i kauoha ʻia e kāu kauka.

E ale i nā papa holoʻokoʻa; mai hoʻokaʻawale, nau aʻe, hoʻonā a wāwahi paha iā lākou.

ʻAʻole loaʻa ʻo Dalfampridine i nā hale kūʻai lāʻau. Hiki iā ʻoe ke kiʻi i ka dalfampridine ma o ka leka uila mai kahi kauka lāʻau lapaʻau kūikawā. E nīnau i kāu kauka inā he nīnau kāu e pili ana i ka loaʻa ʻana o kāu lāʻau.

Hiki i ka Dalfampridine ke kōkua i ka hoʻomaikaʻi ʻana i kou hele wāwae ʻana inā ʻoe e hoʻomau i ka lawe. E 6 mau pule paha a lōʻihi paha ma mua o kou ʻike ʻana i ka pono piha o ka dalfampridine. E hoʻomau i ka lawe dalfampridine ʻoiai ʻoe e manaʻo maikaʻi. Mai hōʻoki i ka lawe ʻana i ka dalfampridine me ke kamaʻilio ʻole ʻana me kāu kauka.

E hāʻawi aku kāu kauka a kauka paha iā ʻoe i ka pepa ʻikepili a ka mea hana (Kauka Lapaʻau) ke hoʻomaka ʻoe i ka lāʻau me dalfampridine a i kēlā me kēia manawa e hoʻopiha hou i kāu kauka. E heluhelu pono i ka ʻike a nīnau i kāu kauka a kauka paha inā he nīnau kāu. Hiki iā ʻoe ke kipa aku i ka pūnaewele ʻo Food and Drug Administration (FDA) (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) e kiʻi i ke alakaʻi Medication.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka lawe ʻana i ka dalfampridine,

• e haʻi i kāu kauka a me kāu kauka lāʻau inā he maʻi ʻoe i ka dalfampridine, 4-aminopyridine (4-AP, fampridine) i hoʻomākaukau ʻia e kāu kauka lāʻau, nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i nā papa dalfampridine. E noi i kāu kauka lāʻau a nānā i ke alakaʻi lāʻau no kahi papa inoa o nā mea hoʻohui.
• e haʻi i kāu kauka a me ka mea kauka lāʻau he aha nā lāʻau lapaʻau a me nā lāʻau ʻole i kuhikuhi ʻia, nā wikamina, nā mea hoʻopihaʻai, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe E haʻi pono i kekahi ʻano o ka 4-aminopyridine (4-AP, fampridine) i hoʻomākaukau ʻia e kāu kauka lāʻau. Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
• e haʻi i kāu kauka inā loaʻa mua ʻoe i ka hopu ʻana a inā loaʻa ʻoe i ka maʻi puʻupaʻa. E haʻi paha kāu kauka iā ʻoe ʻaʻole e lawe i ka dalfampridine.
• e haʻi i kāu kauka inā loaʻa iā ʻoe kahi electroencephalogram abnormal (EEG, kahi hoʻāʻo e ana i ka hana uila i ka lolo).
• e haʻi i kāu kauka inā hāpai ʻoe, hoʻolālā e hāpai, a i ʻole e hānai umauma ana. Inā hāpai ʻoe i ka lawe ʻana i ka dalfampridine, e kāhea i kāu kauka.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.

E haʻalele i ka lāʻau i haʻalele ʻia a hoʻomau i kāu papa hana maʻamau. Mai lawe ma mua o ʻelua mau kaha o ka dalfampridine i loko o 24 mau hola a mai lawe i kahi lāʻau pālua e pani no kahi mea i hala.

Hoʻokumu paha ʻo Dalfampridine i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

• paʻakikī e hiamoe a hiamoe paha
• ʻūpā
• ʻeha poʻo
• nausea
• puʻuwai puʻuwai
• kōpaʻa
• nāwaliwali
• ʻeha kua
• paʻakikī me ke kaulike
• ke kaumaha o nā ʻōuli sclerosis he nui
• puhi ʻana, ʻili ʻana, a i ʻole ka ʻili ʻana o ka ʻili
• ʻeha a huhū paha i ka ihu a i ʻole ka puʻu

Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli, e kāhea i kāu kauka a i ʻole e kiʻi koke i ka lāʻau olakino olakino

• ka hopu ʻana
• ʻeha, paʻakikī, a i ʻole ka urino pinepine
• ke kunu a i ʻole ke anuanu
• ʻeha ma ka hope, ʻaoʻao, a i ʻole ka ʻōpū

Hoʻokumu paha ʻo Dalfampridine i nā hopena ʻē aʻe. Kāhea i kāu kauka inā he pilikia ʻokoʻa kāu i ka lawe ʻana i kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

E mālama i kēia lāʻau i loko o ka pahu i komo ai, pani paʻa ʻia, a ʻaʻole hiki i nā kamaliʻi. E mālama iā ia i ka mahana wela o ka lumi a ma kahi o ka wela a me ka momona (ʻaʻole i ka lua.

Pono e hoʻolei ʻia nā lāʻau i koi ʻole ʻia i nā ala kūikawā e hōʻoia i ka hiki ʻole i nā holoholona, ​​nā keiki, a me nā poʻe ʻē aʻe ke hoʻopau iā lākou. Eia nō naʻe, ʻaʻole pono ʻoe e kaomi i kēia lāʻau i ka lua. Akā, ʻo ke ala ʻoi loa e hoʻolilo i kāu lāʻau i loko o kahi papahana hoʻihoʻi lāʻau. E kamaʻilio me kāu kauka lāʻau a kāhea paha i kāu ʻōpala a me nā hana hoʻopōʻaiapuni kūloko e aʻo e pili ana i nā papahana hoʻihoʻi i kou kaiāulu. E ʻike i ka pūnaewele palekana o kā FDA's Disposal of Medicines (http://goo.gl/c4Rm4p) no ka ʻike hou aku inā ʻaʻohe ou komo i kahi papahana hoʻihoʻi.

He mea nui e mālama i nā lāʻau āpau mai ka maka a hiki i nā keiki e like me nā ipu (e like me nā minder pill i kēlā me kēia pule a me nā mea no nā kulu maka, nā kalima, nā pākuʻi, a me nā inhalers) ʻaʻole pale keiki a hiki i nā keiki ʻōpio ke wehe maʻalahi iā lākou. No ka pale ʻana i nā keiki ʻōpio mai ka lāʻau make, laka mau i nā pāpale palekana a kau koke i ka lāʻau i kahi palekana - kahi i luna a mamao a mai ko lākou alo a hiki. http://www.upandaway.org

I ke kumu o ka overdose, e kāhea i ka helpline kaohi lāʻau make ma 1-800-222-1222. Loaʻa ka ʻike ma ka pūnaewele ma https://www.poisonhelp.org/help. Inā ua hina ka mea i hoʻomāinoino ʻia, loaʻa ka hopu ʻana, pilikia i ka hanu ʻana, a i ʻole hiki ʻole ke ala aʻe, e kāhea koke i nā lawelawe kūikawā ma 911.

Hiki i nā ʻōuli o ka overdose ke hoʻopili i kēia mau mea:

• huikau
• ka hopu ʻana
• ke hoʻoluliluli ʻole ʻole ʻana i kahi ʻāpana o kou kino
• ka houʻu ʻana
• poho hoʻomanaʻo
• pilikia pilikia ʻōlelo
• nāwaliwali

E mālama i nā manawa a pau me kāu kauka a me ka hale hana. E kauoha kāu kauka i kekahi mau hoʻokolohua lab e nānā i ka pane o kou kino i ka dalfampridine.

Mai ʻae i kahi mea ʻē aʻe e lawe i kāu lāʻau. E nīnau i kāu kauka lāʻau i nā nīnau āu e pili ana i ka hoʻopiha hou ʻana i kāu kuhikuhi.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• ʻO Ampyra^®

• 4-aminopyridine
• 4-AP
• hoʻolauleʻa